{
  "retracted": false,
  "timestamp": 1579651200000,
  "updates": [
    {
      "timestamp": 1591731570473,
      "identifier": {
        "doi": "10.1186/s13058-019-1240-y"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1186/s13058-019-1196-y"
  },
  "journal": "Breast Cancer Research",
  "publisher": "Springer Science and Business Media LLC",
  "title": "Correction to: NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer"
}
